FOR RESEARCH USE ONLY  •  NOT FDA APPROVED  •  MUST BE 21+  •  RESEARCH PURPOSES ONLY

GLP-2T (Teduglutide): Chemistry Profile & Research Overview

← Back to Research Hub
Educational & Research Information Only. All content on this page relates to scientific research and chemistry. ITide Laboratories does not provide guidance on human use of any compound. This content is not medical advice.

What Is GLP-2T?

GLP-2T is a synthetic 33-amino-acid peptide assigned CAS number 197922-42-2, also known by the chemical name teduglutide and the development code ALX-0600. It is an analog of glucagon-like peptide-2 (GLP-2), an endogenous mammalian peptide encoded within the proglucagon gene. Structurally, GLP-2T differs from native GLP-2 by a single substitution at position 2 — an alanine residue is replaced with glycine (Gly-2) — yielding the systematic descriptor [Gly2]-GLP-2(1-33). This single substitution confers resistance to N-terminal cleavage by dipeptidyl peptidase-IV (DPP-IV), a serine protease that rapidly inactivates the native peptide. As a research-grade synthetic peptide, GLP-2T is widely used in vitro and in non-human systems as a model substrate in peptide-stability research, in solid-phase peptide synthesis (SPPS) methodology studies, and as a tool compound in receptor-ligand binding characterization.

Chemical Properties

CAS Number197922-42-2
Chemical NameTeduglutide; [Gly2]-GLP-2(1-33)
SynonymsALX-0600, GLP-2 (Gly2) analog
Molecular FormulaC164H252N44O55S
Molecular Weight3752.13 g/mol
Amino Acid Length33 residues
Sequence (single-letter)HGDGSFSDEMNTILDNLAARDFINWLIQTKITD
AppearanceWhite to off-white lyophilized powder
SolubilitySoluble in bacteriostatic water and most aqueous buffers
Storage2–8 °C protected from light; long-term at –20 °C
PubChem CID16139605

Historical Development and Discovery

The GLP-2T sequence was first characterized in the late 1990s as part of a structure-activity research program investigating analogs of glucagon-like peptide-2. Native GLP-2 had been identified as a proglucagon-derived 33-residue peptide secreted from intestinal L-cells, but its very short plasma half-life in research models — driven by rapid N-terminal cleavage at the Ala-2–Asp-3 bond by DPP-IV — limited its experimental utility. Investigators at NPS Pharmaceuticals (later acquired by Shire) systematically substituted residues at the DPP-IV recognition site and identified [Gly2]-GLP-2 as the analog with the most favorable enzymatic stability profile while retaining receptor binding affinity. The compound entered the chemical literature under the development code ALX-0600 and the INN teduglutide. It has since become a standard reference compound in peptide methodology research.

Chemical Architecture and Structural Features

The Gly-2 Substitution and DPP-IV Resistance

The defining structural feature of GLP-2T is the single-residue substitution at position 2: native GLP-2 carries an alanine at this position, which is recognized by DPP-IV as the second residue of an X-Pro or X-Ala dipeptide motif. Replacement with glycine — the smallest proteinogenic amino acid — alters the steric and electronic environment of the scissile bond sufficiently to abolish DPP-IV cleavage in standard in vitro assays. Glycine substitution at residue 2 is a well-established strategy in incretin-peptide medicinal chemistry research and is also used in GLP-1 analogs.

Solid-Phase Synthesis Considerations

GLP-2T is typically produced by Fmoc-based solid-phase peptide synthesis (SPPS) followed by RP-HPLC purification. The 33-residue length, single methionine, and absence of cysteine residues simplify the synthesis relative to disulfide-containing peptides. Common challenges discussed in the synthesis literature include aspartimide formation at the multiple Asp-Gly junctions and methionine oxidation during cleavage, both of which are addressed through standard protecting-group and scavenger strategies.

Receptor and Sequence Context

The native GLP-2 receptor is a class-B G-protein-coupled receptor (GPCR), and GLP-2T retains binding affinity for this receptor in published in vitro assays. The N-terminal histidine and the conserved residues required for receptor engagement are preserved in the analog.

Research Mechanisms

In published in vitro and non-human research, GLP-2T has been characterized as a receptor agonist at the GLP-2 receptor with substantially extended biochemical half-life relative to native GLP-2 in DPP-IV-containing matrices. This profile makes it a useful comparator in pharmacology screens of synthetic peptides, in receptor-binding methodology research, and in protease-stability studies of peptide drug candidates. ITide Labs supplies GLP-2T as a research-grade reference standard for these applications.

Research Areas

  • Peptide-stability and protease-resistance methodology research
  • Solid-phase peptide synthesis and aspartimide-suppression studies
  • Receptor-binding and class-B GPCR pharmacology research
  • Reference standard in analytical method development (HPLC, mass spectrometry)
  • Comparative structure-activity research on the proglucagon peptide family

Quality Assurance

ITide Labs releases each lot of GLP-2T against an independent third-party Certificate of Analysis. Lot-specific COAs are published on the corresponding product page once analysis is complete. Identity is confirmed by HPLC-MS, purity by RP-HPLC-UV, and endotoxin levels by kinetic chromogenic LAL assay. Lyophilized material is stored at 2–8 °C protected from light and is supplied with batch-specific documentation.

Frequently Asked Questions

What is the CAS number for GLP-2T?

The CAS number for GLP-2T (teduglutide) is 197922-42-2.

What is the molecular weight of GLP-2T?

The monoisotopic molecular weight of GLP-2T is 3752.13 g/mol. The empirical formula is C164H252N44O55S.

What is the amino acid sequence of GLP-2T?

The single-letter sequence of GLP-2T is HGDGSFSDEMNTILDNLAARDFINWLIQTKITD — a 33-residue peptide bearing a glycine substitution at position 2.

How does GLP-2T differ from native GLP-2?

GLP-2T differs from native human GLP-2 by a single substitution at position 2: alanine is replaced with glycine ([Gly2]-GLP-2). This substitution confers resistance to DPP-IV cleavage while preserving receptor binding affinity in published in vitro research assays.

What is the development code for GLP-2T?

GLP-2T was originally developed under the code ALX-0600 by NPS Pharmaceuticals. The INN is teduglutide.

Why is GLP-2T used in research?

GLP-2T is used as a reference standard in peptide methodology research, in protease-stability assays, in receptor-binding studies on the class-B GPCR family, and as a model compound in solid-phase peptide synthesis characterization.

What laboratory storage does GLP-2T require?

Lyophilized GLP-2T should be stored at 2–8 °C protected from light for short-term storage and at –20 °C for long-term storage. Reconstituted solutions should be aliquoted and stored frozen.

Is GLP-2T available in different sizes from ITide Labs?

ITide Labs supplies GLP-2T as a 60 mg lyophilized lot. Lot-specific Certificates of Analysis are published on the product page once independent third-party characterization is complete.

Citation

ITide Labs. GLP-2T (Teduglutide): Chemistry Profile and Research Overview. Las Vegas, NV: ITide Labs LLC; 2026.

Research Use Only. This product is supplied for laboratory research purposes by qualified professionals only.

JOIN THE WAITLIST We will inform you when the product arrives in stock. Please leave your valid email address below.